TriSalus inks SPAC merger to fund cancer trials of pressure-enabled drug delivery technology
Fierce Pharma
NOVEMBER 15, 2022
TriSalus inks SPAC merger to fund cancer trials of pressure-enabled drug delivery technology. Tue, 11/15/2022 - 10:03.
Fierce Pharma
NOVEMBER 15, 2022
TriSalus inks SPAC merger to fund cancer trials of pressure-enabled drug delivery technology. Tue, 11/15/2022 - 10:03.
Let's personalize your content